文献速递传染病防控与疫情报告免疫规划卫生政策与健康促进

呼吸道合胞病毒感染的防控进展与挑战

[Advances and challenges in the prevention and control of respiratory syncytial virus infection].
PubMed 文献 · Zhonghua Yu Fang Yi Xue Za Zhi · 2026-01-01

本文系统综述呼吸道合胞病毒(RSV)的流行病学特征与疾病负担,从疫苗研发、抗病毒药物与单克隆抗体应用、非药物干预三方面梳理防控策略,分析病毒变异与免疫逃逸、宿主免疫应答复杂性及全球卫生资源分配不均等挑战,提出构建精准化多层次综合防控体系的建议。

要点

  • RSV对婴幼儿、老年人及免疫功能低下者危害显著,是重要公共卫生问题。
  • 防控需兼顾疫苗、抗病毒药物与单克隆抗体、非药物干预三个维度。
  • 未来应完善监测、优化研发、强化多学科合作并推进资源公平配置。

核心结论

  • 应通过完善流行病学监测、优化疫苗与药物研发、强化多学科合作及推进全球资源公平配置,构建精准化多层次的RSV综合防控体系。

研究设计与样本

  • 本文为综述,系统梳理RSV流行病学特征、疾病负担、防控策略进展及核心挑战。

主要发现

  • RSV是全球急性呼吸道感染的重要病原体,对婴幼儿、老年人及免疫功能低下人群危害显著。
  • RSV流行病学特征涵盖全球流行趋势、季节性分布、病毒亚型遗传多样性及高危人群与危险因素。
  • 防控挑战包括病毒变异与免疫逃逸、宿主免疫应答复杂性及全球公共卫生资源分配不均衡。

临床怎么用

  • 防控应同时关注疫苗研发、抗病毒药物与单克隆抗体应用及非药物干预措施。
  • 需加强流行病学监测体系以支撑精准防控。
  • 应推进全球卫生资源公平配置以改善RSV管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Respiratory syncytial virus (RSV) is a predominant pathogen responsible for acute respiratory tract infections globally. It poses substantial health threats to infants, young children, the elderly, and immunocompromised individuals, constituting a critical public health concern. This article systematically reviews the epidemiological features of RSV, encompassing global epidemic trends, seasonal distribution patterns, genetic diversity of viral subtypes, as well as high-risk populations and associated risk factors, and elaborates on its disease burden across diverse regions and populations. Additionally, it summarizes the current progress and core strategies for RSV prevention and control from three perspectives: vaccine development, the clinical application of antiviral agents and monoclonal antibodies, and non-pharmaceutical interventions. Furthermore, this review analyzes the key challenges constraining effective RSV management, including viral variation and immune escape, the complexity of host immune responses, and the inequitable distribution of global public health resources. On this basis, we propose that a precise, multi-level, and integrated prevention and control system should be established in the future by enhancing epidemiological surveillance systems, optimizing vaccine and drug research and development technologies, strengthening interdisciplinary collaboration, and advancing the equitable allocation of global health resources. The findings of this review provide a reliable reference for fundamental research and public health practice targeting RSV prevention and control. 呼吸道合胞病毒(RSV)是全球范围内引发急性呼吸道感染的重要病原体,尤其对婴幼儿、老年人及免疫功能低下人群危害显著,已成为突出的公共卫生问题。本文综述RSV的流行病学特征,包括全球流行趋势、季节性分布、病毒亚型遗传多样性及高危人群与危险因素,以及在不同地区和人群中的疾病负担。同时,从疫苗研发、抗病毒药物与单克隆抗体应用、非药物干预措施3个维度,梳理当前RSV防控的主要策略,分析病毒变异与免疫逃逸、宿主免疫应答复杂性、全球公共卫生资源分配不均衡等核心挑战。在此基础上,提出未来需通过完善流行病学监测体系、优化疫苗与药物研发技术、强化多学科交叉合作及推进全球资源公平配置,构建精准化、多层次的综合防控体系。.

来源:Zhonghua Yu Fang Yi Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Chen JD, Zheng XT, Li YG, et al. [Advances and challenges in the prevention and control of respiratory syncytial virus infection]. Zhonghua Yu Fang Yi Xue Za Zhi. 2026. PMID: 42893913. doi:10.3760/cma.j.cn112150-20251215-01181

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。